Corrigendum: Melatonin Promotes the Therapeutic Effect of Mesenchymal Stem Cells on Type 2 Diabetes Mellitus by Regulating TGF-β Pathway
Balun Li1 
Xuedi Cheng1 
Aili Aierken1 
Jiaxin Du2,3 Wenlai He1 
Mengfei Zhang1 
Ning Tan1 Zheng Kou1 
Sha Peng1 Wenwen Jia4 
Haiyang Tang1,5 
Jinlian Hua1*- 1Shaanxi Centre of Stem Cells Engineering and Technology, College of Veterinary Medicine, Northwest A&F University, Xianyang, China
- 2Department of Animal Engineering, Yangling Vocational and Technical College, Xianyang, China
- 3Department of Veterinary Medicine, College of Animal Sciences, Institute of Preventive Veterinary Sciences, Zhejiang University, Hangzhou, China
- 4Shanghai East Hospital, East Hospital Affiliated to Tongji University, Shanghai, China
- 5State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
A Corrigendum on
Melatonin Promotes the Therapeutic Effect of Mesenchymal Stem Cells on Type 2 Diabetes Mellitus by Regulating TGF-β Pathway
by Li, B., Cheng, X., Aierken, A., Du, J., He, W., Zhang, M., Tan, N., Kou, Z., Peng, S., Jia, W., Tang, H., and Hua, J. (2021). Front. Cell Dev. Biol. 9:722365. doi: 10.3389/fcell.2021.722365
In the published article, there was an error regarding the affiliation for Haiyang Tang. As well as having affiliation 1, they should also have “State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: melatonin, adipose-derived mesenchymal stem cells, type 2 diabetes mellitus, TGF-β, inflammation, canine
Citation: Li B, Cheng X, Aierken A, Du J, He W, Zhang M, Tan N, Kou Z, Peng S, Jia W, Tang H and Hua J (2021) Corrigendum: Melatonin Promotes the Therapeutic Effect of Mesenchymal Stem Cells on Type 2 Diabetes Mellitus by Regulating TGF-β Pathway. Front. Cell Dev. Biol. 9:799571. doi: 10.3389/fcell.2021.799571
Received: 21 October 2021; Accepted: 15 November 2021;
Published: 07 December 2021.
Edited and Reviewed by:
Frontiers in Cell and Developmental Biology Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Li, Cheng, Aierken, Du, He, Zhang, Tan, Kou, Peng, Jia, Tang and Hua. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jinlian Hua, jinlianhua@nwsuaf.edu.cn